RIGANTI, Chiara
RIGANTI, Chiara
ONCOLOGIA
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells
2019-01-01 Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth
2015-01-01 Capello, Michela; Ferri-Borgogno, Sammy; Principe, Moitza; Chattaragada, Michelle Samuel; Riganti, Chiara; Zhou, Weidong; Follia, Laura; Liotta, Lance A.; Petricoin, Emanuel F.; Cappello, Paola; Novelli, Francesco
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
Antioxidants prevent the RhoA inhibition evoked by crocidolite asbestos in human mesothelial and mesothelioma cells
2011-01-01 E. Gazzano; E. Aldieri; C. Riganti; F. Silvagno; S. Orecchia; P.G. Betta; S. Doublier; M. Polimeni; A. Bosia; D. Ghigo
Cardiac glycosides as new modulators of cholesterol metabolism
2012-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation
2013-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1
2012-01-01 I. Campia; J. Kopecka ;G. Pescarmona; D. Ghigo ; C. Riganti
Characterization and toxicity of zinc-containing bioactive glasses
2005-01-01 V. Aina; C. Costamagna; E.Gazzano; D. Ghigo; G. Lusvardi; G. Malavasi; C. Morterra; A. Perardi; C. Riganti
Computational modeling of pancreatic cancer cells metabolism
2015-01-01 Niccolò Totis, Chiara Fornari, Laura Follia, Chiara Riganti, Marco Beccuti, Francesco Novelli, Gianfranco Balbo, Francesca Cordero
Dealing with indetermination in biochemical networks
2017-01-01 Totis, Niccolò; Beccuti, Marco; Cordero, Francesca; Follia, Laura; Riganti, Chiara; Novelli, Francesco; Balbo, Gianfranco
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis
2009-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Digoxin and oubain increase the synthesis of cholesterol in human liver cells
2011-01-01 Joanna Kopecka; Ivana Campia; Amalia Bosia; Chiara Riganti
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY.
2019-01-01 Stefano Guglielmo, Marialessandra Contino, Chiara Riganti, Barbara Rolando, Loretta Lazzarato
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells
2020-01-01 Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M.
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin.
2015-01-01 Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S.
Experimental glioblastoma in Fisher rat model: treatment with a biocompatible system as carrier of methotrexate drug.
2015-01-01 Biasibetti E; Valazza A; Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Panciani PP; Riganti C; Annovazzi L; Caldera V; Schiffer D; Lanotte M; Capucchio M.T.
Functionalization of nanodiamonds with hyaluronic acid: a study for their potential Applications in radiosensitization and selective tumor detection
2023-01-01 S. Sturari, V. Varzi , P. Aprà , G. Tomagra , V. Monti, V. Bincoletto, B. Zurletti, E. A. Durisi, S. Arpicco , C. Riganti , P. Olivero, F. Picollo,
GIFC-2018 - BOOK OF ABSTRACTS
2018-01-01 muntoni e, battaglia l, marini e, giorgis m, lazzarato l, salaroglio ic, riganti c, martina k
Hazard determinants of carbon nanotubes (cnts) driving molecular initiating events (mies) in adverse outcome pathways (aops) of airways diseases
2018-01-01 E Bergamaschi, E Aldieri, E Gazzano, E Polimeni, C Riganti, O Bussolati, M Allegri, MG Bianchi, F Donato, A Marucco, I Fenoglio
HIF-1 alpha Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target
2016-01-01 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, Fr; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells | 2019 | Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta | |
| Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth | 2015 | Capello, Michela; Ferri-Borgogno, Sammy; Principe, Moitza; Chattaragada, Michelle Samuel; Riganti, Chiara; Zhou, Weidong; Follia, Laura; Liotta, Lance A.; Petricoin, Emanuel F.; Cappello, Paola; Novelli, Francesco | |
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| Antioxidants prevent the RhoA inhibition evoked by crocidolite asbestos in human mesothelial and mesothelioma cells | 2011 | E. Gazzano; E. Aldieri; C. Riganti; F. Silvagno; S. Orecchia; P.G. Betta; S. Doublier; M. Polimeni; A. Bosia; D. Ghigo | |
| Cardiac glycosides as new modulators of cholesterol metabolism | 2012 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti | |
| Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation | 2013 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti | |
| Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1 | 2012 | I. Campia; J. Kopecka ;G. Pescarmona; D. Ghigo ; C. Riganti | |
| Characterization and toxicity of zinc-containing bioactive glasses | 2005 | V. Aina; C. Costamagna; E.Gazzano; D. Ghigo; G. Lusvardi; G. Malavasi; C. Morterra; A. Perardi; C. Riganti | |
| Computational modeling of pancreatic cancer cells metabolism | 2015 | Niccolò Totis, Chiara Fornari, Laura Follia, Chiara Riganti, Marco Beccuti, Francesco Novelli, Gianfranco Balbo, Francesca Cordero | |
| Dealing with indetermination in biochemical networks | 2017 | Totis, Niccolò; Beccuti, Marco; Cordero, Francesca; Follia, Laura; Riganti, Chiara; Novelli, Francesco; Balbo, Gianfranco | |
| Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis | 2009 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Digoxin and oubain increase the synthesis of cholesterol in human liver cells | 2011 | Joanna Kopecka; Ivana Campia; Amalia Bosia; Chiara Riganti | |
| EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY. | 2019 | Stefano Guglielmo, Marialessandra Contino, Chiara Riganti, Barbara Rolando, Loretta Lazzarato | |
| Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells | 2020 | Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M. | |
| Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin. | 2015 | Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S. | |
| Experimental glioblastoma in Fisher rat model: treatment with a biocompatible system as carrier of methotrexate drug. | 2015 | Biasibetti E; Valazza A; Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Panciani PP; Riganti C; Annovazzi L; Caldera V; Schiffer D; Lanotte M; Capucchio M.T. | |
| Functionalization of nanodiamonds with hyaluronic acid: a study for their potential Applications in radiosensitization and selective tumor detection | 2023 | S. Sturari, V. Varzi , P. Aprà , G. Tomagra , V. Monti, V. Bincoletto, B. Zurletti, E. A. Durisi, S. Arpicco , C. Riganti , P. Olivero, F. Picollo, | |
| GIFC-2018 - BOOK OF ABSTRACTS | 2018 | muntoni e, battaglia l, marini e, giorgis m, lazzarato l, salaroglio ic, riganti c, martina k | |
| Hazard determinants of carbon nanotubes (cnts) driving molecular initiating events (mies) in adverse outcome pathways (aops) of airways diseases | 2018 | E Bergamaschi, E Aldieri, E Gazzano, E Polimeni, C Riganti, O Bussolati, M Allegri, MG Bianchi, F Donato, A Marucco, I Fenoglio | |
| HIF-1 alpha Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target | 2016 | Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, Fr; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M |